Trinity Biotech (TRIB) received a Nasdaq noncompliance notification for not meeting the regulator's minimum bid price requirement of $1 a share for continued listing.
The deadline for regaining compliance is Sept. 10, the company said Friday in a statement.
The notice has no immediate impact on the American depositary share listing, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.